Nifty
Sensex
:
:
11914.40
40359.41
-54.00 (-0.45%)
-215.76 (-0.53%)

Pharmaceuticals & Drugs

Rating :
63/99  (View)

BSE: 531599 | NSE: FDC

194.90
1.05 (0.54%)
22-Nov-2019 | 3:54PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  194.95
  •  197.90
  •  188.45
  •  193.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  941735
  •  1835.44
  •  219.00
  •  148.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,310.89
  • 17.21
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,290.24
  • N/A
  • 2.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.24%
  • 1.45%
  • 12.92%
  • FII
  • DII
  • Others
  • 0.03%
  • 5.89%
  • 10.47%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.65
  • 4.16
  • 2.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.99
  • 2.26
  • -1.88

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.43
  • 3.29
  • -2.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.56
  • 20.74
  • 19.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.69
  • 2.95
  • 2.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.04
  • 12.85
  • 12.70

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Net Sales
346.12
0.00
0.00
343.52
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
272.25
0.00
0.00
265.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
73.87
0.00
0.00
78.48
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
21.34%
0.00%
22.84%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
16.90
0.00
0.00
9.79
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.82
0.00
0.00
0.81
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
9.57
0.00
0.00
9.36
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
80.38
0.00
0.00
78.09
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
25.97
0.00
0.00
21.73
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
54.41
0.00
0.00
56.36
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
15.72%
0.00%
16.41%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
3.16
0.00
0.00
3.21
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
1,090.70
1,075.07
1,013.87
994.32
889.31
845.85
772.83
710.54
711.67
632.14
Net Sales Growth
-
1.45%
6.04%
1.97%
11.81%
5.14%
9.45%
8.77%
-0.16%
12.58%
 
Cost Of Goods Sold
-
345.14
352.08
339.05
357.93
272.91
266.16
311.11
237.54
253.93
221.09
Gross Profit
-
745.56
722.99
674.81
636.38
616.40
579.69
461.71
473.00
457.75
411.05
GP Margin
-
68.36%
67.25%
66.56%
64.00%
69.31%
68.53%
59.74%
66.57%
64.32%
65.03%
Total Expenditure
-
859.68
848.38
770.40
765.58
690.76
641.47
591.97
547.15
545.76
465.62
Power & Fuel Cost
-
24.61
22.00
21.55
23.14
20.18
18.45
16.85
13.77
12.73
11.45
% Of Sales
-
2.26%
2.05%
2.13%
2.33%
2.27%
2.18%
2.18%
1.94%
1.79%
1.81%
Employee Cost
-
225.57
216.67
191.08
175.76
137.58
122.05
107.52
99.02
85.57
68.69
% Of Sales
-
20.68%
20.15%
18.85%
17.68%
15.47%
14.43%
13.91%
13.94%
12.02%
10.87%
Manufacturing Exp.
-
62.25
58.77
49.40
36.44
97.27
88.65
22.88
70.20
67.06
60.66
% Of Sales
-
5.71%
5.47%
4.87%
3.66%
10.94%
10.48%
2.96%
9.88%
9.42%
9.60%
General & Admin Exp.
-
59.45
61.55
53.35
49.97
41.43
35.99
34.32
33.79
31.76
32.39
% Of Sales
-
5.45%
5.73%
5.26%
5.03%
4.66%
4.25%
4.44%
4.76%
4.46%
5.12%
Selling & Distn. Exp.
-
78.92
75.96
64.36
57.73
64.96
58.43
56.15
55.45
55.12
46.74
% Of Sales
-
7.24%
7.07%
6.35%
5.81%
7.30%
6.91%
7.27%
7.80%
7.75%
7.39%
Miscellaneous Exp.
-
63.73
61.35
51.61
64.61
56.43
51.73
43.13
37.36
39.60
46.74
% Of Sales
-
5.84%
5.71%
5.09%
6.50%
6.35%
6.12%
5.58%
5.26%
5.56%
3.89%
EBITDA
-
231.02
226.69
243.47
228.74
198.55
204.38
180.86
163.39
165.91
166.52
EBITDA Margin
-
21.18%
21.09%
24.01%
23.00%
22.33%
24.16%
23.40%
23.00%
23.31%
26.34%
Other Income
-
43.47
50.96
50.22
39.00
45.72
42.00
46.36
28.65
28.25
31.43
Interest
-
1.44
1.40
1.41
1.40
1.81
3.10
1.60
1.41
1.44
1.45
Depreciation
-
33.24
35.14
34.62
33.73
38.81
24.91
27.90
18.43
17.36
15.88
PBT
-
239.80
241.11
257.65
232.62
203.65
218.36
197.72
172.20
175.37
180.62
Tax
-
66.85
67.12
63.30
63.48
55.51
83.04
42.55
38.11
24.48
31.49
Tax Rate
-
28.01%
27.84%
25.14%
27.29%
27.26%
38.03%
21.52%
22.13%
13.96%
17.43%
PAT
-
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
149.13
PAT before Minority Interest
-
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
149.13
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
15.76%
16.18%
18.59%
17.01%
16.66%
16.00%
20.08%
18.87%
21.20%
23.59%
PAT Growth
-
-1.23%
-7.68%
11.43%
14.17%
9.48%
-12.79%
15.72%
-11.13%
1.18%
 
Unadjusted EPS
-
9.74
9.76
10.60
9.48
8.33
7.59
8.51
7.30
8.11
7.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,445.24
1,276.11
1,270.20
1,082.47
936.38
845.30
784.24
695.42
616.39
526.62
Share Capital
17.52
17.52
17.86
17.86
17.86
17.86
18.16
18.37
18.54
18.71
Total Reserves
1,427.72
1,258.59
1,252.34
1,064.61
918.52
827.43
766.08
677.05
597.86
507.91
Non-Current Liabilities
229.17
211.41
216.67
19.93
24.06
30.97
31.32
30.24
29.59
28.69
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.22
0.56
0.77
1.27
Unsecured Loans
0.49
0.60
0.69
0.79
0.90
1.07
1.24
1.45
1.73
3.69
Long Term Provisions
213.96
194.12
198.60
0.50
0.56
0.00
0.00
0.00
2.20
0.00
Current Liabilities
497.43
480.07
389.40
163.42
187.97
195.69
153.97
139.01
123.45
123.99
Trade Payables
77.61
97.32
75.10
82.59
87.17
80.05
61.04
57.64
45.90
42.52
Other Current Liabilities
61.67
68.78
64.11
50.16
36.61
42.87
35.98
30.09
29.60
37.31
Short Term Borrowings
0.00
0.00
0.00
0.00
1.00
1.11
1.14
1.29
1.27
0.00
Short Term Provisions
358.15
313.97
250.19
30.67
63.19
71.66
55.81
49.99
46.68
44.16
Total Liabilities
2,171.84
1,967.59
1,876.27
1,265.82
1,148.41
1,071.96
969.53
864.67
769.43
679.30
Net Block
682.19
673.64
678.05
675.16
393.04
284.40
289.19
293.04
276.74
255.51
Gross Block
817.80
776.49
745.84
708.81
629.67
470.42
453.02
430.01
396.15
358.77
Accumulated Depreciation
135.61
102.84
67.79
33.65
236.62
186.02
163.82
136.96
119.41
103.26
Non Current Assets
1,113.46
976.64
957.93
742.46
646.27
619.47
558.20
418.02
322.50
285.32
Capital Work in Progress
12.38
12.84
6.32
19.92
28.80
18.10
7.22
10.72
10.18
30.07
Non Current Investment
179.11
74.07
54.49
39.43
216.72
186.92
245.15
96.20
14.01
-0.26
Long Term Loans & Adv.
239.08
215.28
218.46
7.70
6.37
128.71
15.13
17.41
19.42
0.00
Other Non Current Assets
0.71
0.81
0.60
0.25
1.33
1.33
1.51
0.65
2.15
0.00
Current Assets
1,058.38
990.94
918.34
523.36
502.13
452.03
410.83
446.10
446.88
393.98
Current Investments
405.93
397.16
436.53
285.41
272.49
229.90
170.91
243.92
248.86
229.42
Inventories
173.79
160.49
137.16
130.91
123.22
103.00
99.71
102.92
97.42
90.25
Sundry Debtors
87.53
81.66
76.06
61.94
61.04
59.36
43.23
41.97
40.75
36.81
Cash & Bank
21.26
29.30
28.47
18.02
14.95
23.43
36.50
16.78
17.76
16.77
Other Current Assets
369.88
10.68
9.68
6.74
30.44
36.33
60.49
40.52
42.09
20.73
Short Term Loans & Adv.
358.56
311.65
230.44
20.36
14.77
28.18
48.89
34.66
39.71
20.73
Net Current Assets
560.94
510.87
528.94
359.94
314.16
256.33
256.86
307.09
323.43
269.99
Total Assets
2,171.84
1,967.58
1,876.27
1,265.82
1,148.40
1,071.97
969.53
864.66
769.44
679.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
112.43
149.84
154.49
174.30
127.64
149.72
149.94
144.33
120.74
168.55
PBT
237.75
240.63
257.71
232.15
203.65
218.36
197.72
172.20
175.37
180.62
Adjustment
-2.95
0.39
-10.88
2.41
-1.40
-7.67
-14.20
-2.62
1.31
-6.45
Changes in Working Capital
-48.30
-23.24
-19.23
-4.54
-11.78
7.09
4.14
9.01
-20.98
21.18
Cash after chg. in Working capital
186.49
217.78
227.60
230.02
190.48
217.79
187.66
178.59
155.70
195.35
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-74.06
-67.94
-70.14
-55.73
-62.84
-68.07
-37.72
-34.26
-34.97
-26.79
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
-2.97
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-120.33
20.11
-143.55
-73.05
-88.57
-55.38
-107.18
-108.25
-33.00
-126.95
Net Fixed Assets
-40.93
-36.71
-24.24
-81.62
-169.89
-28.28
-19.51
-25.53
-17.54
-30.20
Net Investments
-113.70
19.79
-166.18
170.44
-72.39
-0.76
-75.95
-83.31
-33.71
-118.17
Others
34.30
37.03
46.87
-161.87
153.71
-26.34
-11.72
0.59
18.25
21.42
Cash from Financing Activity
-0.07
-169.43
0.35
-96.98
-47.76
-75.25
-62.83
-58.18
-57.51
-37.31
Net Cash Inflow / Outflow
-7.96
0.52
11.29
4.27
-8.69
19.09
-20.06
-22.10
30.22
4.29
Opening Cash & Equivalents
28.13
27.10
16.25
12.17
23.26
4.17
24.23
46.33
16.11
11.81
Closing Cash & Equivalent
19.92
28.13
27.10
16.25
14.56
23.26
4.17
24.23
46.33
16.11

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
82.86
73.17
71.42
60.87
52.62
47.47
43.30
37.95
33.35
28.22
ROA
8.30%
9.05%
12.00%
14.01%
13.34%
13.26%
16.92%
16.41%
20.83%
24.34%
ROE
12.63%
13.67%
16.02%
16.76%
16.64%
16.63%
21.01%
20.48%
26.44%
31.48%
ROCE
17.64%
19.04%
21.51%
23.15%
23.02%
27.12%
26.85%
26.34%
30.73%
37.97%
Fixed Asset Turnover
1.37
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
1.86
Receivable days
28.31
26.58
23.96
22.06
24.19
21.70
19.72
20.88
19.59
20.47
Inventory Days
55.93
50.15
46.55
45.58
45.45
42.89
46.90
50.57
47.41
52.78
Payable days
40.35
41.32
40.83
44.81
47.89
44.12
40.39
37.33
32.94
34.20
Cash Conversion Cycle
43.89
35.41
29.68
22.84
21.74
20.47
26.23
34.12
34.06
39.05
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
Interest Cover
166.95
172.62
179.60
167.11
113.30
71.41
124.23
122.88
122.86
125.55

News Update


  • FDC to acquire ‘ENTEROPLUS’ from GlaxoSmithKline Pharmaceuticals
    18th Oct 2019, 09:07 AM

    The Company would have acquired all the rights of this Trademark/Brand ‘ENTEROPLUS’

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.